Skip to content
Screener

Relay Therapeutics, Inc. RLAY Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$83.71M-18.9%-$73.29M+4.9%-$54.89M+27.8%-$74.15M+15.8%-$70.38M+23.7%
$360K-64.1%$504K-58.3%$599K-55.1%$748K-45.3%$1M-26.8%
$9.18M-36.7%$10.54M-45.5%$13.07M-25.9%$15.53M-30.9%$14.5M-46.0%
-$54.11M+2.1%-$51.11M+30.2%-$44.87M+22.5%-$62.12M+17.3%-$55.26M+16.1%
$1K$0-100%$26K+136%
-$353.03M-570%$32.9M-22.5%$35.46M$39.73M+131%$75.15M+65.0%
$323.74M$138.78M$934K+16.8%$17K-100.0%
$120.57M+492%-$8.47M+69.8%-$22.38M-227%

FAQ

How much cash does Relay Therapeutics, Inc. generate?
Relay Therapeutics, Inc. (RLAY) generated -$212.2M in operating cash flow over the trailing twelve months.
Where does Relay Therapeutics, Inc.'s cash flow data come from?
Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.